Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia-Unzueta, M. T.
Right arrow Articles by Amado, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia-Unzueta, M. T.
Right arrow Articles by Amado, J. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 6 999-1003, Copyright © 1998 by American Diabetes Association

ARTICLES

Plasma adrenomedullin levels in type 1 diabetes. Relationship with clinical parameters

MT Garcia-Unzueta, C Montalban, C Pesquera, JR Berrazueta and JA Amado
Endocrine Unit, Hospital Universitario Marques de Valdecilla, Universidad de Cantabria, Santander, Spain.

OBJECTIVE: To assess the relationship between plasma adrenomedullin (AM) levels and the presence of microvascular complications in type 1 diabetic patients. RESEARCH DESIGN AND METHODS: We measured plasma AM and cAMP levels in 103 type 1 diabetic patients (46 without complications, 24 with retinopathy only, 14 with microalbuminuria but normal kidney function, and 19 with renal insufficiency) and 41 matched healthy control subjects. RESULTS: Patients with renal insufficiency had higher levels of AM and cAMP than all other groups. Patients with only retinopathy showed a trend to have higher levels than patients without complications. There were no differences among all other groups. There was a significant correlation between AM and cAMP in the total diabetic group (rs = 0.36, P < 0.001) but not in the control group. In multiple regression analysis, plasma AM demonstrated significant relationships with creatinine clearance (beta = -0.31, P = 0.004) and duration of the disease (beta = 0.28, P = 0.008). CONCLUSIONS: Plasma AM and cAMP are increased in type 1 diabetic patients with renal insufficiency. Creatinine clearance (CrClc) and duration of the disease are related to plasma AM levels in these patients.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
S. C. Lim, N. G. Morgenthaler, T. Subramaniam, Y. S. Wu, S. K. Goh, and C. F. Sum
The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes
Diabetes Care, June 1, 2007; 30(6): 1513 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Bomberger, N. Parameswaran, C. S. Hall, N. Aiyar, and W. S. Spielman
Novel Function for Receptor Activity-modifying Proteins (RAMPs) in Post-endocytic Receptor Trafficking
J. Biol. Chem., March 11, 2005; 280(10): 9297 - 9307.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
N. Fukai, T. Yoshimoto, T. Sugiyama, N. Ozawa, R. Sato, M. Shichiri, and Y. Hirata
Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E56 - E62.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. Dobrzynski, D. Montanari, J. Agata, J. Zhu, J. Chao, and L. Chao
Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1291 - E1298.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. P. Hinson, S. Kapas, and D. M. Smith
Adrenomedullin, a Multifunctional Regulatory Peptide
Endocr. Rev., April 1, 2000; 21(2): 138 - 167.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
T. Hata, T. Yanagihara, H. Tanaka, C. Yamashiro, and K. Kanenishi
Maternal ophthalmic artery Doppler velocimetry in type 1 diabetes during pregnancy
Hum. Reprod., January 1, 2000; 15(1): 222 - 223.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.